Clifford Hallam Healthcare (CH2) are pleased to announce the appointment of Carmen Riley to the board of directors effective July 1st, 2019.
Carmen has been a key member of the CH2 team for over 10 years and has contributed significantly to the success of the business during this time.
Carmen has successfully led the CH2 sales team through multiple large-scale projects including our recent launch into the Retail Pharmacy market.
“This appointment is in recognition of the high regard we have for Carmen’s work ethic and dedication, in addition to her skills and knowledge of the healthcare market” said CH2’s Chief Executive Officer David Collins.
CH2 are looking forward to continuing to work with Carmen as we execute our strategy of being the preferred independent wholesaler to the healthcare market.